Hormone-sensitive Prostate Cancer

• CLINICAL_TRIALS research · 2025-10-29
  Clinical Trial Update: Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer [Phase 2]

  A Phase II clinical trial evaluating PSA-triggered, individualized management for metastatic hormone-sensitive prostate cancer, currently re…

• CLINICAL_TRIALS research · 2025-09-26
  Clinical Trial Update: A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer [Phase 3]

  Phase 3 randomized platform trial investigating treatments for metastatic hormone-sensitive prostate cancer; the study is currently recruiti…

• CLINICAL_TRIALS research · 2025-09-18
  Clinical Trial Update: Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients

  This clinical trial update covers apalutamide in metastatic hormone-sensitive prostate cancer. The trial is currently active but not recruit…

• CLINICAL_TRIALS research · 2025-09-04
  Clinical Trial Update: A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

  A clinical trial from Anhui Medical University aims to study castration-resistant prostate cancer progression and immune interactions in met…

• CLINICAL_TRIALS research · 2025-09-03
  Clinical Trial Update: Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment [NA]

  A randomized trial compares abiraterone acetate plus androgen deprivation therapy (APA+ADT) versus APA+ADT with local treatment in metastati…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-06-22
  Clinical Trial Update: Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer

  This clinical trial update describes a planned evaluation of triplet therapy with darolutamide plus androgen-deprivation therapy and docetax…

• CLINICAL_TRIALS research · 2025-04-09
  Clinical Trial Update: ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer [Phase 3]

  Phase 3 biomarker-driven trial (ProBio) in metastatic prostate cancer is currently recruiting, enrolling patients with metastatic castration…

• CLINICAL_TRIALS research · 2024-12-20
  Clinical Trial Update: Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders) [Phase 3]

  Phase 3 trial update evaluating standard of care with or without lutetium-177 Lu-PSMA-617 in newly diagnosed metastatic hormone-sensitive pr…

• CLINICAL_TRIALS research · 2024-10-24
  Clinical Trial Update: An Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical Care

  An observational study conducted in Belgium assessing the use of darolutamide as part of combination therapy for metastatic hormone-sensitiv…